In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

The trial was tailored to evaluate the therapy at multiple ascending dose levels, with three dose administrations per level.

Mayo Clinic researchers have discovered a new immunotherapy target, a cryptic antigen, that may be key in helping the immune system fight tumors in ovarian cancer. The study, published in Science ...